{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:19:21Z","timestamp":1791580761917,"version":"4.3.4"},"reference-count":165,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022CMMRWA"],"award-info":[{"award-number":["2022CMMRWA"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["29829"],"award-info":[{"award-number":["29829"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["30710"],"award-info":[{"award-number":["30710"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["28054"],"award-info":[{"award-number":["28054"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020349","name":"Italian Foundation for Research on Pancreatic Diseases","doi-asserted-by":"publisher","award":["J38D19000690001"],"award-info":[{"award-number":["J38D19000690001"]}],"id":[{"id":"10.13039\/100020349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dld.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T22:25:40Z","timestamp":1774218340000},"page":"726-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives"],"prefix":"10.1016","volume":"58","author":[{"given":"Silvia","family":"Carrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-0860","authenticated-orcid":false,"given":"Michele","family":"Bevere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-2778","authenticated-orcid":false,"given":"Donatella","family":"Delle Cave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-9653","authenticated-orcid":false,"given":"Manuel","family":"Gentiluomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-4908","authenticated-orcid":false,"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.03.002_bib0001","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2025.0473","article-title":"National Cancer System Characteristics and Global Pan-Cancer Outcomes","volume":"11","author":"Dee","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/DLMT1294","article-title":"Multi-cancer early detection tests for general population screening: a systematic literature review","volume":"29","author":"Wade","year":"2025","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.dld.2026.03.002_bib0003","first-page":"11","article-title":"Cancer diagnosis: from tumor to liquid biopsy and beyond","volume":"19","author":"Vaidyanathan","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.dld.2026.03.002_bib0004","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.dld.2026.03.002_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","article-title":"Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0006","first-page":"eaay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.dld.2026.03.002_bib0007","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nmeth.3014","article-title":"Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study","volume":"11","author":"Mestdagh","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.dld.2026.03.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102172","article-title":"Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review","volume":"52","author":"Veronese","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0009","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cllc.2022.11.007","article-title":"Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)","volume":"24","author":"Raez","year":"2023","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"10.1016\/j.dld.2026.03.002_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081152","article-title":"Liquid biopsy as surrogate for tissue for molecular profiling in pancreatic cancer: a meta-analysis towards precision medicine","volume":"11","author":"Luchini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.dld.2026.03.002_bib0011","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.annonc.2022.08.089","article-title":"Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)","volume":"33","author":"Bayle","year":"2022","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.dld.2026.03.002_bib0012","first-page":"511","article-title":"Enhancing early detection of pancreatic cancer in genetically predisposed individuals: integrating advanced imaging modalities with emerging biomarkers and liquid biopsy","volume":"30","author":"Abdel-Razeq","year":"2025","journal-title":"Biologics"},{"issue":"4","key":"10.1016\/j.dld.2026.03.002_bib0013","doi-asserted-by":"crossref","first-page":"739","DOI":"10.14309\/ajg.0000000000002546","article-title":"Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer","volume":"119","author":"Paiella","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.002_bib0014","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4251\/wjgo.v10.i10.317","article-title":"Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma","volume":"10","author":"Riva","year":"2018","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gutjnl-2021-326550","article-title":"Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype","volume":"72","author":"Liffers","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.dld.2026.03.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217662","article-title":"Pancreatic cancer precursor lesions - Can immunotherapy prevent progression into pancreatic ductal adenocarcinoma?","volume":"619","author":"Enzler","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.dld.2026.03.002_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2024.12.005","article-title":"Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer","volume":"109","author":"Corradi","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.dld.2026.03.002_bib0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.6437","article-title":"Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization","volume":"266","author":"Pea","year":"2025","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2026.03.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/srep41064","article-title":"Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes","volume":"7","author":"Schlitter","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/14737159.2024.2348676","article-title":"Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond","volume":"24","author":"Ciulla","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.dld.2026.03.002_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0022","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-23-0519","article-title":"KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma","volume":"23","author":"Than","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.dld.2026.03.002_bib0023","first-page":"1801","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science (1979)"},{"key":"10.1016\/j.dld.2026.03.002_bib0024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.dld.2026.03.002_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","article-title":"Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications","volume":"70","author":"Luchini","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.dld.2026.03.002_bib0026","first-page":"36","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"39","author":"Ying","year":"2025","journal-title":"Genes Dev"},{"key":"10.1016\/j.dld.2026.03.002_bib0027","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.trecan.2024.01.009","article-title":"Fusion genes in pancreatic tumors","volume":"10","author":"Gkountakos","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0028","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13046-020-01732-6","article-title":"KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities","volume":"39","author":"Luchini","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0029","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","article-title":"Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma","volume":"28","author":"Philip","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1078-0432.CCR-20-2831","article-title":"Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics","volume":"27","author":"Topham","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0031","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41392-023-01380-0","article-title":"To metabolomics and beyond: a technological portfolio to investigate cancer metabolism","volume":"8","author":"Danzi","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.dld.2026.03.002_bib0032","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","article-title":"Emerging mechanisms and promising approaches in pancreatic cancer metabolism","volume":"15","author":"Wu","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.dld.2026.03.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54975-8","article-title":"Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer","volume":"15","author":"Veghini","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2026.03.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191936","article-title":"Pancreatic ductal adenocarcinoma: the Everest of cancer biology","volume":"135","author":"Than","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2026.03.002_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.dld.2026.03.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191943","article-title":"Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention","volume":"135","author":"Maddipati","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2026.03.002_bib0037","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5306\/wjco.v14.i11.504","article-title":"Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0038","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ejso.2017.01.241","article-title":"Clinical impact of circulating tumor cells and therapy response in pancreatic cancer","volume":"43","author":"Okubo","year":"2017","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.dld.2026.03.002_bib0039","article-title":"CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches","volume":"5","author":"Tang","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.dld.2026.03.002_bib0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.hpb.2019.11.003","article-title":"Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2020","journal-title":"HPB"},{"key":"10.1016\/j.dld.2026.03.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.112940","article-title":"Single-cell omics: a new perspective for early detection of pancreatic cancer?","volume":"190","author":"Wang","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0042","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2407-12-178","article-title":"Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition","volume":"12","author":"Gorges","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0043","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Alix-Panabi\u00e8res","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0044","doi-asserted-by":"crossref","first-page":"107223","DOI":"10.18632\/oncotarget.19928","article-title":"Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis","volume":"8","author":"Stephenson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2026.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/SLA.0000000000001600","article-title":"Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma","volume":"264","author":"Poruk","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2026.03.002_bib0046","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pan.2020.11.022","article-title":"Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications","volume":"21","author":"Pang","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.dld.2026.03.002_bib0047","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-023-01880-1","article-title":"Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis","volume":"22","author":"Stoecklein","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0048","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1158\/1078-0432.CCR-18-0120","article-title":"Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer","volume":"24","author":"Effenberger","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0049","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12880","article-title":"Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer","volume":"53","author":"Cheng","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.dld.2026.03.002_bib0050","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1245\/s10434-017-6290-8","article-title":"Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer","volume":"25","author":"Court","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0051","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.7150\/thno.28745","article-title":"Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Varillas","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.dld.2026.03.002_bib0052","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bjc.2016.121","article-title":"Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer","volume":"114","author":"Ankeny","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0053","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.dld.2026.03.002_bib0054","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2026.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00432-020-03219-5","article-title":"Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas","volume":"146","author":"Dhayat","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0056","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41419-019-1770-3","article-title":"Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study","volume":"10","author":"Alborelli","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.dld.2026.03.002_bib0057","first-page":"67","article-title":"Soluble normal and mutated DNA sequences from single-copy genes in human blood","volume":"3","author":"Sorenson","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2026.03.002_bib0058","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/cncr.29364","article-title":"Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer","volume":"121","author":"Kinugasa","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0059","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.molonc.2015.11.012","article-title":"Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer","volume":"10","author":"Tjensvoll","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0060","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2026.03.002_bib0061","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.dld.2026.03.002_bib0062","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pan.2016.12.011","article-title":"Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue","volume":"17","author":"Ako","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.dld.2026.03.002_bib0063","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2018.09.022","article-title":"Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer","volume":"156","author":"Bernard","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.03.002_bib0064","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1373\/clinchem.2016.257469","article-title":"Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer","volume":"62","author":"Brychta","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2026.03.002_bib0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s12885-015-1779-7","article-title":"Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer","volume":"15","author":"Earl","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0066","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.mpa.0000202938.63084.e3","article-title":"Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA","volume":"32","author":"Marchese","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2026.03.002_bib0067","doi-asserted-by":"crossref","first-page":"83446","DOI":"10.18632\/oncotarget.13225","article-title":"A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative","volume":"8","author":"Pishvaian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2026.03.002_bib0068","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/2159-8290.CD-15-0274","article-title":"Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas","volume":"5","author":"Zill","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.dld.2026.03.002_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.09.042","article-title":"Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA","volume":"55","author":"Zvereva","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.dld.2026.03.002_bib0070","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.21037\/jgo-23-114","article-title":"Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas","volume":"14","author":"Caughey","year":"2023","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0071","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cancergen.2017.08.006","article-title":"Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer","volume":"218\u2013219","author":"Vietsch","year":"2017","journal-title":"Cancer Genet"},{"key":"10.1016\/j.dld.2026.03.002_bib0072","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47489-7","article-title":"Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer","volume":"9","author":"Mohan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0073","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00535-020-01724-5","article-title":"Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance","volume":"55","author":"Okada","year":"2020","journal-title":"J Gastroenterol"},{"issue":"15","key":"10.1016\/j.dld.2026.03.002_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153687","article-title":"Somatic mutation profiling in the liquid biopsy and clinical analysis of hereditary and familial pancreatic cancer cases reveals kras negativity and a longer overall survival","volume":"13","author":"Earl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.dld.2026.03.002_bib0075","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-020-1063-5","article-title":"Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies","volume":"26","author":"Nakamura","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2026.03.002_bib0076","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2016.04.034","article-title":"Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"151","author":"Berger","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.03.002_bib0077","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74868-2","article-title":"GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype","volume":"10","author":"Hata","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0078","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00535-020-01724-5","article-title":"Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance","volume":"55","author":"Okada","year":"2020","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.002_bib0079","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.4344","article-title":"Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas","volume":"233","author":"Amato","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.dld.2026.03.002_bib0080","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/1878-0261.13719","article-title":"KRAS and GNAS mutations in cell-free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms-an observational pilot study","volume":"19","author":"Nitschke","year":"2025","journal-title":"Mol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0081","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41598-021-81065-2","article-title":"Molecular analysis of cyst fluids improves the diagnostic accuracy of pre-operative assessment of pancreatic cystic lesions","volume":"11","author":"Haeberle","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0082","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1038\/ncomms8686","article-title":"Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients","volume":"6","author":"Sausen","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2026.03.002_bib0083","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-025-01696-0","article-title":"KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma","volume":"18","author":"Yousef","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0084","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.pan.2025.06.013","article-title":"Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma","volume":"25","author":"Furukawa","year":"2025","journal-title":"Pancreatology"},{"key":"10.1016\/j.dld.2026.03.002_bib0085","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/1078-0432.CCR-19-0197","article-title":"Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer","volume":"25","author":"Groot","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0086","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.molonc.2015.11.012","article-title":"Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer","volume":"10","author":"Tjensvoll","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0087","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdz200","article-title":"Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer","volume":"30","author":"Lee","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0088","article-title":"Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227366","article-title":"Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer","volume":"14","author":"Watanabe","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2026.03.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2023.102007","article-title":"Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis","volume":"51","author":"Alqahtani","year":"2023","journal-title":"Surg Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0091","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/annonc\/mdy417","article-title":"Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer","volume":"29","author":"Kruger","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0092","article-title":"Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0093","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1038\/s41598-017-08297-z","article-title":"Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer","volume":"7","author":"Del Re","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0094","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227366","article-title":"Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer","volume":"14","author":"Watanabe","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2026.03.002_bib0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/bjc.2016.175","article-title":"Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer","volume":"115","author":"Hadano","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0096","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12885-020-07736-x","article-title":"Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer","volume":"21","author":"Hussung","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0097","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/bjc.2017.479","article-title":"KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study","volume":"118","author":"Nakano","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0098","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/2767-9764.CRC-22-0343","article-title":"Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma","volume":"2","author":"Christenson","year":"2022","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.dld.2026.03.002_bib0099","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer","volume":"13","author":"Mattox","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.dld.2026.03.002_bib0100","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","article-title":"False-Positive Plasma Genotyping Due to Clonal Hematopoiesis","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0101","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1158\/1078-0432.CCR-24-3335","article-title":"Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients","volume":"31","author":"Magee","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0102","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.dld.2026.03.002_bib0103","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/cr.2017.106","article-title":"5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages","volume":"27","author":"Song","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0104","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/cr.2017.121","article-title":"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13148-016-0286-2","article-title":"Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma","volume":"8","author":"Henriksen","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.dld.2026.03.002_bib0106","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1038\/s41467-020-18965-w","article-title":"Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA","volume":"11","author":"Guler","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.dld.2026.03.002_bib0107","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/1878-0261.13643","article-title":"Circulating cell-free DNA methylation-based multi-omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma","volume":"18","author":"Zhao","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0108","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.cgh.2023.03.016","article-title":"Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA","volume":"21","author":"Haan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.002_bib0109","first-page":"639","article-title":"Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer","volume":"73","author":"Ben-Ami","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.dld.2026.03.002_bib0110","first-page":"926","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science (1979)"},{"issue":"42","key":"10.1016\/j.dld.2026.03.002_bib0111","article-title":"A single-molecule bioelectronic portable array for early diagnosis of pancreatic cancer precursors","volume":"35","author":"Genco","year":"2023","journal-title":"Adv Mater"},{"issue":"10","key":"10.1016\/j.dld.2026.03.002_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100790","article-title":"minimally invasive detection of high-risk pancreatic cystic neoplasms using a novel multiparametric single-molecule biosensor","volume":"4","author":"Esposito","year":"2025","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.dld.2026.03.002_bib0113","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.dld.2026.03.002_bib0114","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-024-03067-y","article-title":"Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics","volume":"43","author":"Shi","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0115","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.24.00287","article-title":"Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer","volume":"43","author":"Yin","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.31662\/jmaj.2023-0009","article-title":"Roles of MicroRNAs in Disease Biology","volume":"6","author":"Suzuki","year":"2023","journal-title":"JMA J"},{"key":"10.1016\/j.dld.2026.03.002_bib0117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10585-023-10256-0","article-title":"miRNAs in pancreatic cancer progression and metastasis","volume":"41","author":"Mok","year":"2024","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.dld.2026.03.002_bib0118","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1586\/14737159.2015.1112273","article-title":"Circulating microRNAs as diagnostic biomarkers for pancreatic cancer","volume":"15","author":"Le Large","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.dld.2026.03.002_bib0119","article-title":"Clinical Value of Circulating microRNAs in Diagnosis and Prognosis of Pancreatic Cancer: A Systematic Review","volume":"15","author":"Senaratne","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.dld.2026.03.002_bib0120","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/s41598-017-01904-z","article-title":"Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation","volume":"7","author":"Qu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0121","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41419-018-1182-9","article-title":"miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.dld.2026.03.002_bib0122","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.dld.2026.03.002_bib0123","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2026.03.002_bib0124","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/s41598-021-82266-5","article-title":"Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma","volume":"11","author":"Khan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2025.101988","article-title":"Genetic landscape for screening and early diagnosis of pancreatic ductal adenocarcinoma: is there a signature?","volume":"74","author":"Campa","year":"2025","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.002_bib0126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jmedgenet-2020-106961","article-title":"Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction","volume":"58","author":"Galeotti","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.dld.2026.03.002_bib0127","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.34956","article-title":"Circulating microRNAs in association with pancreatic cancer risk within 5\u2009years","volume":"155","author":"Wang","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2014.10.020","article-title":"Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer","volume":"81","author":"Rachagani","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dld.2026.03.002_bib0129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40169-018-0192-7","article-title":"Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges","volume":"7","author":"Lane","year":"2018","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.dld.2026.03.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104807","article-title":"Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance","volume":"212","author":"Toledano-Fonseca","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.dld.2026.03.002_bib0131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0132","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222406","article-title":"New insights into extracellular vesicle biogenesis and function","volume":"132","author":"Latifkar","year":"2019","journal-title":"J Cell Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0133","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","article-title":"Exosomes in tumor microenvironment influence cancer progression and metastasis","volume":"91","author":"Kahlert","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.dld.2026.03.002_bib0134","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0135","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/ijms27052470","article-title":"Connecting the dots: milestones in the history of extracellular vesicle research","volume":"27","author":"Guzowska","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0136","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0137","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/bs.ctm.2025.07.002","article-title":"Extracellular vesicles as biomarkers in cancer diagnosis and prognosis","volume":"96","author":"Silvestrini","year":"2025","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.dld.2026.03.002_bib0138","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s12672-025-03916-y","article-title":"Role of exosomes in cancer: from diagnosis to therapy","volume":"16","author":"Esparvarinha","year":"2025","journal-title":"Discover Oncology"},{"key":"10.1016\/j.dld.2026.03.002_bib0139","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s13287-025-04667-x","article-title":"MiRNA delivery systems in cancer stem cell therapy: exosomes versus chitosan nanoparticles","volume":"16","author":"Valizadeh-Otaghsara","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"19","key":"10.1016\/j.dld.2026.03.002_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199323","article-title":"Exosomal mirnas: key regulators of the tumor microenvironment and cancer stem cells","volume":"26","author":"Wang","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.dld.2026.03.002_bib0141","article-title":"Navigating the landscape of exosomal micrornas: charting their pivotal role as biomarkers in hematological malignancies","volume":"11","author":"Fazio","year":"2025","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.dld.2026.03.002_bib0142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.dld.2026.03.002_bib0143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.dld.2026.03.002_bib0144","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fonc.2019.00614","article-title":"The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3892\/ol.2021.12559","article-title":"Role of exosomes in pancreatic cancer","volume":"21","author":"Liu","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.dld.2026.03.002_bib0146","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-020-01287-y","article-title":"Exosomal miRNA signatures of pancreatic lesions","volume":"20","author":"Vicentini","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2026.03.002_bib0147","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3389\/fonc.2020.01456","article-title":"Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer","volume":"10","author":"Nannan","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0148","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2020.01.001","article-title":"From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer","volume":"51","author":"Han","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.dld.2026.03.002_bib0149","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1520717","article-title":"Translating the multifaceted use of liquid biopsy to management of early disease in pancreatic adenocarcinoma","volume":"15","author":"Cox","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2026.03.002_bib0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-024-12463-8","article-title":"Early detection of pancreatic cancer by liquid biopsy \u201cPANLIPSY\u201d: a french nation-wide study project","volume":"24","author":"Bardol","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0151","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2024.07.048","article-title":"Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study","volume":"23","author":"Engels","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.03.002_bib0152","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.03.002_bib0153","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/cancers13010039","article-title":"Bile-Based Cell-Free DNA Analysis Is a Reliable Diagnostic Tool in Pancreatobiliary Cancer","volume":"13","author":"Driescher","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.dld.2026.03.002_bib0154","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.3390\/ijms26188763","article-title":"KRAS Copy Number Gain in Cell-Free DNA Analysis-Based Liquid Biopsy of Plasma and Bile in Patients with Various Pancreatic Neoplasms","volume":"26","author":"Jain","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0155","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/diagnostics12112704","article-title":"Genetic Analyses of Cell-Free DNA in Pancreatic Juice or Bile for Diagnosing Pancreatic Duct and Biliary Tract Strictures","volume":"12","author":"Nagai","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.dld.2026.03.002_bib0156","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/15384047.2019.1638685","article-title":"Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma","volume":"20","author":"Terasawa","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.dld.2026.03.002_bib0157","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41568-025-00882-z","article-title":"Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization","volume":"26","author":"Ward","year":"2026","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dld.2026.03.002_bib0158","doi-asserted-by":"crossref","first-page":"e3407","DOI":"10.1097\/MD.0000000000003407","article-title":"A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases","volume":"95","author":"Tien","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2026.03.002_bib0159","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jhbp.601","article-title":"Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients","volume":"26","author":"Kawamura","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.dld.2026.03.002_bib0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11894-019-0733-2","article-title":"EUS-Guided Portal Venous Sampling of Circulating Tumor Cells","volume":"21","author":"Chapman","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.dld.2026.03.002_bib0161","first-page":"94","article-title":"The Impact of Hemolysis on Cell-Free microRNA Biomarkers","volume":"4","author":"Kirschner","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.dld.2026.03.002_bib0162","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/ol.2016.5452","article-title":"A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs","volume":"13","author":"Pizzamiglio","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.dld.2026.03.002_bib0163","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00068-025-02822-w","article-title":"Influence of hemolysis, lipemia and bilirubin on biobank sample quality- origin and interference in the use for extracellular vesicle (EV) and MiRNA analyses","volume":"51","author":"Weber","year":"2025","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.dld.2026.03.002_bib0164","doi-asserted-by":"crossref","first-page":"31438","DOI":"10.1021\/acsnano.5c06940","article-title":"Advanced Cancer Liquid Biopsy Platform for miRNA Detection in Extracellular Vesicles Using CRISPR\/Cas13a and Gold Nanoarrays","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.dld.2026.03.002_bib0165","article-title":"High-Throughput Quantification of miRNA-3\u2032-Untranslated-Region Regulatory Effects","author":"Mastriano","year":"2024","journal-title":"BioRxiv [Preprint]"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582600304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582600304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:35:57Z","timestamp":1778859357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582600304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":165,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S159086582600304X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}